BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 108 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,975,000 | +16.7% | 37,391 | +35.4% | 0.01% | -11.1% |
| Q2 2020 | $1,692,000 | -9.8% | 27,611 | -16.7% | 0.01% | -25.0% |
| Q1 2020 | $1,876,000 | -27.5% | 33,161 | -27.1% | 0.01% | +33.3% |
| Q4 2019 | $2,589,000 | +15.0% | 45,465 | +8.0% | 0.01% | +12.5% |
| Q3 2019 | $2,252,000 | -4.0% | 42,086 | +7.1% | 0.01% | 0.0% |
| Q2 2019 | $2,346,000 | +10.8% | 39,286 | +15.7% | 0.01% | 0.0% |
| Q1 2019 | $2,117,000 | +2.6% | 33,963 | -0.3% | 0.01% | -11.1% |
| Q4 2018 | $2,064,000 | +3.3% | 34,063 | -0.3% | 0.01% | +28.6% |
| Q3 2018 | $1,998,000 | +33.5% | 34,163 | +2.4% | 0.01% | +16.7% |
| Q2 2018 | $1,497,000 | -9.8% | 33,363 | -10.8% | 0.01% | -25.0% |
| Q1 2018 | $1,659,000 | – | 37,423 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |